Department of Surgery, University of Alberta, Edmonton, AB, Canada.
Transpl Int. 2010 Apr 1;23(4):432-5. doi: 10.1111/j.1432-2277.2009.00998.x. Epub 2009 Nov 18.
Hepatopulmonary syndrome (HPS) is a complication of portal hypertension, defined by the presence of liver disease, abnormal pulmonary gas exchange and evidence of intrapulmonary vascular dilatations producing a right-to-left intrapulmonary shunt. Liver transplantation (LT) is the treatment of choice; however, severe hypoxemia (PaO(2) < 50 mmHg on room air) is considered a contraindication to LT. This approach disadvantages some patients, particularly young patients with no intrinsic cardio-respiratory disease. We discuss one such patient who improved with LT despite having extremely severe HPS (PaO2 < 29 mmHg).
肝肺综合征(HPS)是门静脉高压症的并发症,定义为存在肝脏疾病、肺气体交换异常和肺内血管扩张证据,导致右向左肺内分流。肝移植(LT)是治疗的首选方法;然而,严重的低氧血症(在空气环境下 PaO(2) < 50 mmHg)被认为是 LT 的禁忌症。这种方法对一些患者不利,特别是没有内在心肺疾病的年轻患者。我们讨论了这样一个患者,尽管患有极其严重的 HPS(PaO2 < 29 mmHg),但通过 LT 得到了改善。